Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market a generic antibiotic drug. The company has received final approval from the US Food & Drug Administration (USFDA) for Clindamycin Hydrochloride Capsules, a generic version of Pfizer's Cleocin capsules, Glenmark Pharma said in a statement.
Enforcement Report - Week of February 1, 2023
Enforcement Report - Week of December 22, 2021
Taro Pharms` Generic Clindamycin Phosphate Receives Approval In US
Drug labels for doxycycline, clindamycin and caffeine citrate now include better information for healthcare providers on recommended usage and dosage in pediatric populations. The data that informed these label changes came from research funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health.
Union Quimico Farmaceutica Fails EDQM Inspection
Enforcement Report - Week of April 10, 2019
Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a generic version of BenzaClin® Gel, 1%|5%, of Valeant Bermuda.
Micro Labs's Generic Clindamycin Hydrochloride Receives Approval in US
Enforcement Report - Week of May 23, 2018